A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries.
Alfalasi A, Ameen A, Al Lafi A, El Gendi A, Saad W, Ismail A, Al Naeem A, Goturu S, Al-Ahmed N, Dayem HA, Nanda A, Tawdy A, Alogayell L, Iraqi M, Abdul Hay N, El Enezi M, Walkhinde S, Kamal M, Aldhuhoori M, Almesfer A, Abd Elwhab A, Al Hawsawi KA, Barakat A, Chmayse S, Hafiz M, Chouikrat Z, Fahmy M.
Alfalasi A, et al. Among authors: ismail a.
J Dermatolog Treat. 2025 Dec;36(1):2443110. doi: 10.1080/09546634.2024.2443110. Epub 2025 Jan 6.
J Dermatolog Treat. 2025.
PMID: 39761970